Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Douglas W. Elmendorf Named to Abt Associates' Board of Directors

Abt Associates
Posted on: 12 Jul 18
Douglas W. Elmendorf Named to Abt Associates' Board of Directors

PR Newswire

ROCKVILLE, Md., July 12, 2018

ROCKVILLE, Md., July 12, 2018 /PRNewswire/ -- Douglas W. Elmendorf, Ph. D., Dean of Harvard University'sJohn F. Kennedy School of Government and Don K. Price Professor of Public Policy, has been elected to the Abt Associates Board of Directors.

"Doug Elmendorf is one of the most respected economists in the U.S.," said Abt Associates President and CEO Kathleen Flanagan.  "He has deep knowledge of many of our core research areas, including health care policy and approaches to increasing economic security, and will bring a valuable perspective to our Board and staff."

Before becoming dean of the Kennedy School in 2016, Elmendorf led the Congressional Budget Office from 2009-2015. He has held senior economic positions with the Federal Reserve Board, the Council of Economic Advisors and the Treasury Department, where he was Deputy Assistant Secretary for Economic Policy. 

Elmendorf is the author of more than 30 publications and has testified before Congress on economic issues 50 times since 2005. 

He holds an A.B. from Princeton University, and an A.M. and Economics from Harvard University. 

About Abt Associates

Abt Associates is an engine for social impact, harnessing the power of data and grounded insight to bring people from vulnerability to security worldwide.  We provide research consulting and technical services globally, working in the areas of health, environmental and social policy and international development.

View original content with multimedia:

SOURCE Abt Associates

PR Newswire

Last updated on: 12/07/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.